Interleukin -18 (IL-18) and tumor necrosis factor (TNF) in sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 434s Year: 2002
Evaluation levels of pro-inflammatory cytokines tumour necrosis factor (TNF)-alpha and interleukin (IL) 1-beta in small cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 233s Year: 2001
Cytokines in asthma Source: Eur Respir J 2001; 18: 24S-33S Year: 2001
Tumour necrosis factor and lymphotoxin A polymorphisms: a relationship with COPD and its progression? Source: Eur Respir J 2007; 29: 8-10 Year: 2007
Upregulation of interleukin 13 receptor alpha 2 (IL-13RA2) expression in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 267s Year: 2005
Variation in the tumour necrosis factor gene is not associated with susceptibility to COPD Source: Eur Respir J 2007; 30: 810-812 Year: 2007
Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012
The levels of osteoprotegerin (OPG), interleukin 18 (IL-18) and soluble interleukin 2 receptor (sIL-2R) in serum during chemotherapy of lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 318s Year: 2004
Association of the TNF gene promoter polymorphism with serum tumor necrosis factor-alpha levels in chronic obstructive pulmonary disease patients Source: Eur Respir J 2006; 28: Suppl. 50, 522s Year: 2006
Levels of plasma tumour necrosis factor and soluble tumour necrosis factor receptor in patients with COPD and its relation to glucocorticoid receptor levels Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009
Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers Source: Eur Respir J 2007; 29: 34-41 Year: 2007
Interferon (-alpha, -beta, and -omega) receptor 2 (IFNAR2) is a prognostic biomarker for lung cancer Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer Year: 2011
Relationship between level of transforming growth factor beta 1 (TGF beta 1) and serum amyloid A in COPD patients Source: International Congress 2019 – Research and innovation in airway diseases Year: 2019
Tumour necrosis factor gene polymorphisms and childhood wheezing Source: Eur Respir J 2005; 26: 637-646 Year: 2005
Genetic polymorphism in the human tumor necrosis factor (TNF ) and its association with different clinical types of tuberculosis disease in Peruvian patients Source: Eur Respir J 2004; 24: Suppl. 48, 467s Year: 2004
Transforming growth factor beta (TGFβ)-2 and -3 gene polymorphisms in different phenotypes of sarcoidosis Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009
Soluble interleukin 2 receptor ( sIL-2R ) during chemotherapy of the lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 74s Year: 2002
Does tumour necrosis factor-alpha (TNF-alpha) induced by lipopolysaccharide have a positive feedback effect on the up-regulation of interleukin-8 (IL-8) messenger RNA by monocytes from COPD patients? Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013
Evaluation levels of pro-inflammatory cytokines tumour necrosis factor (TNF)-alpha and interferon (IFN)-gamma in lung cancer complicated with metastatic pleurisy Source: Eur Respir J 2001; 18: Suppl. 33, 233s Year: 2001
Study of tumor necrosis factor family genes in two phenotypes of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 87s Year: 2002